CD4 and neoplasm: Similarly, the negative correlation with CD4+ memory T cells, which play a crucial role in anti-tumor immunity and can suppress tumor growth by enhancing anti-tumor immune responses (Kim and Cantor, 2014; Seung et al., 2022; Krueger et al., 2021), indicates that PRR13 might inhibit their function within the tumor microenvironment.